JP2004359653A - Method for treatment and prevention of severe acute respiratory syndrome (sars) with deuterium-decreased water (superlight water) - Google Patents

Abstract

<P>PROBLEM TO BE SOLVED: To provide an effective method for the treatment and prevention of severe acute respiratory syndrome (SARS) to which effective treatment is not yet developed and the present treatment is the transfer to a hospital to leave a patient to spontaneous healing and for which preventing method is lacked except for the wearing of mask, washing of hands, gargling, sterilization, or the like. <P>SOLUTION: Severe acute respiratory syndrome (SARS) is treated and prevented by enhancing immunological competence by lowering the heavy water concentration in the body by using a deuterium-decreased water (superlight water). <P>COPYRIGHT: (C)2005,JPO&NCIPI

Description

[0001]
BACKGROUND OF THE INVENTION
The present invention treats and prevents severe acute respiratory syndrome (SARS) with deuterium-reduced water (superlight water).
[0002]
[Prior art]
An effective treatment method for severe acute respiratory syndrome (SARS) has not been developed, and the current treatment method is to wait for natural healing after being accommodated in a medical institution.
[0003]
Moreover, there are only preventive methods such as wearing a mask, washing hands, gargle, and disinfecting.
[0004]
[Problems to be solved by the invention]
However, in reality, severe acute respiratory syndrome (SARS) occurs mainly in East Asia, and some effective treatment and prevention method is required.
[0005]
[Means for Solving the Problems]
As a result of diligent research to solve such problems, the present inventors have conducted treatment and prevention of severe acute respiratory syndrome (SARS) with the use of deuterium-reduced water (superlight water) to reduce the concentration of heavy water in the body. The present invention is provided by developing a method for enhancing immunity by reduction.
[0006]
That is, the present invention relates to the use of deuterium-depleted water (superlight water), which is optimal for the treatment and prevention of severe acute respiratory syndrome (SARS), as a raw material for physiology using deuterium-depleted water (superlight water) as a raw material. This is a method for the treatment and prevention of severe acute respiratory syndrome (SARS) characterized by injecting physiological saline into the body by instillation to lower the deuterium concentration in the body.
[0007]
DETAILED DESCRIPTION OF THE INVENTION
In the present invention, deuterium-depleted water (super light water) is drunk and physiological saline using deuterium-depleted water (super light water) as a raw material is injected into the body by infusion to reduce the concentration of heavy water in the body more effectively. .
[0008]
When the deuterium concentration is 149 ppm or less, protein binding is weakened, metabolism is increased, and cell activation and immune cell increase are promoted.
[0009]
【The invention's effect】
As described above, according to the present invention, drinking deuterium-depleted water (superlight water) having a deuterium concentration of 140 ppm or less or instilling physiological saline using deuterium-decreasing water (superlight water) as a raw material. This has the effect of activating cells and increasing immune cells as the deuterium concentration in the body decreases, and by strengthening the immune function of the human body, severe acute respiratory syndrome (Severe Accurate Respiratory Syndrome = SARS) Promotes natural healing. Moreover, it is effective in prevention by strengthening immune function.

Claims (1)

Having deuterium with a content of 140 ppm or less, or as an active agent with a deuterium content of 140 ppm or less, together with a carrier or auxiliary, in the form of a pharmaceutical product or solution Treatment and prevention of Severe Acute Respiratory Syndrome (SARS) with deuterium-reduced water (Super Light Water), an aqueous solution suitable for humans.